Crossject Société Anonyme Future Growth
Future criteria checks 5/6
Crossject Société Anonyme is forecast to grow earnings and revenue by 82.5% and 62.9% per annum respectively while EPS is expected to grow by 1.1% per annum.
Key information
82.5%
Earnings growth rate
1.1%
EPS growth rate
| Medical Equipment earnings growth | 13.8% |
| Revenue growth rate | 62.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 03 Apr 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 67 | 31 | 28 | N/A | 1 |
| 12/31/2025 | 48 | 19 | 13 | N/A | 1 |
| 12/31/2024 | 4 | -15 | -14 | N/A | 1 |
| 12/31/2023 | 13 | -8 | N/A | N/A | N/A |
| 9/30/2023 | 10 | -9 | N/A | N/A | N/A |
| 6/30/2023 | 7 | -10 | -9 | -4 | N/A |
| 3/31/2023 | 7 | -11 | -10 | -5 | N/A |
| 12/31/2022 | 7 | -11 | -12 | -5 | N/A |
| 9/30/2022 | 7 | -11 | N/A | N/A | N/A |
| 6/30/2022 | 6 | -11 | -19 | -9 | N/A |
| 3/31/2022 | 6 | -11 | -16 | -7 | N/A |
| 12/31/2021 | 6 | -11 | -13 | -6 | N/A |
| 9/30/2021 | 6 | -10 | N/A | N/A | N/A |
| 6/30/2021 | 6 | -10 | -13 | -6 | N/A |
| 3/31/2021 | 5 | -10 | -12 | -6 | N/A |
| 12/31/2020 | 5 | -10 | -12 | -5 | N/A |
| 9/30/2020 | 5 | -9 | N/A | N/A | N/A |
| 6/30/2020 | 5 | -7 | -10 | -5 | N/A |
| 3/31/2020 | 5 | -7 | -10 | -5 | N/A |
| 12/31/2019 | 5 | -7 | -10 | -6 | N/A |
| 9/30/2019 | 4 | -10 | N/A | N/A | N/A |
| 6/30/2019 | 3 | -12 | -8 | -5 | N/A |
| 3/31/2019 | 3 | -12 | -10 | -7 | N/A |
| 12/31/2018 | 2 | -11 | -11 | -8 | N/A |
| 9/30/2018 | 3 | -9 | N/A | N/A | N/A |
| 6/30/2018 | 4 | -8 | N/A | N/A | N/A |
| 3/31/2018 | 4 | -8 | N/A | N/A | N/A |
| 12/31/2017 | 3 | -8 | -9 | -5 | N/A |
| 9/30/2017 | 2 | -7 | N/A | N/A | N/A |
| 6/30/2017 | 2 | -7 | N/A | N/A | N/A |
| 3/31/2017 | 2 | -7 | N/A | N/A | N/A |
| 12/31/2016 | 1 | -6 | N/A | -4 | N/A |
| 9/30/2016 | 1 | -6 | N/A | N/A | N/A |
| 6/30/2016 | 1 | -5 | N/A | -4 | N/A |
| 3/31/2016 | 1 | -5 | N/A | -5 | N/A |
| 12/31/2015 | 2 | -6 | N/A | -5 | N/A |
| 9/30/2015 | 2 | -6 | N/A | N/A | N/A |
| 6/30/2015 | 2 | -6 | N/A | -5 | N/A |
| 3/31/2015 | 2 | -5 | N/A | -4 | N/A |
| 12/31/2014 | 1 | -4 | N/A | -3 | N/A |
| 9/30/2014 | 1 | -4 | N/A | N/A | N/A |
| 6/30/2014 | 1 | -3 | N/A | -3 | N/A |
| 3/31/2014 | 1 | -3 | N/A | -2 | N/A |
| 12/31/2013 | 1 | -2 | N/A | -1 | N/A |
| 9/30/2013 | 1 | -1 | N/A | N/A | N/A |
| 6/30/2013 | 1 | -1 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALCJ is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.1%).
Earnings vs Market: ALCJ is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ALCJ is expected to become profitable in the next 3 years.
Revenue vs Market: ALCJ's revenue (62.9% per year) is forecast to grow faster than the French market (5.7% per year).
High Growth Revenue: ALCJ's revenue (62.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ALCJ's Return on Equity is forecast to be high in 3 years time